Investigator Initiated Studies

 

1. University of California San Diego

A single-center, randomized study of Nexagon^® for the treatment of inflammatory lower extremity leg ulcers.

2. University of Auckland

Randomized, prospective, double-masked, vehicle-controlled study to evaluate the safety and efficacy of topical Nexagon^® in subjects with ocular surface chemical burns.

3. University of California San Francisco

Phase 2, randomized, prospective, double-masked, vehicle-controlled, dose-ranging study to evaluate the efficacy and safety of Nexagon^® in subjects with persistent corneal epithelial defects (PED) after either corneal transplant surgery or corneal epithelial debridement during diabetic vitrectomy surgery.